Medindia LOGIN REGISTER
Medindia
Advertisement

Tumor Cells can Be Killed With Nanoparticles and Light Combo

by Rajashri on July 31, 2008 at 3:14 PM
 Tumor Cells can Be Killed With Nanoparticles and Light Combo

A new idea to kill tumour cells with the help of nanoparticles and light has been mooted by University of Virginia medical physicists.

The experts say that their approach employs quantum dots, semiconductor nanostructures that can confine electrons in three dimensions and emit light when exposed to ultraviolet radiation.

Advertisement

Wensha Yang, an instructor in radiation oncology at the university, and his colleagues have found that quantum dots also give off light when exposed to megavoltage x-rays, such as those used in cancer radiotherapy.

According to them, this property makes quantum dots an ideal mediator in therapies employing light-activated compounds to treat cancer.

The scientists have revealed that their technique combines the photosensitizer that is currently used to treat certain kinds of shallowly located tumours, called Photofrin, with quantum dots.
Advertisement

Photofrin is absorbed by cancer cells, and kills cells when activated by exposure to light.

Yang and his colleagues believe that combining Photofrin and quantum dots may create an efficient method to kill even deeply seated cancer cells.

They say that exposure to high doses of radiation would cause the dots to become luminescent and emit light, which in turn would trigger the cancer-killing activity of the Photofrin.

Although the researchers have thus far studied this theory only in cancer cells grown in culture, they think it may work on tumours located too deep within the body to be reached by an external light source.

The researchers also say that the treatment would not harm normal tissues because the toxicity of the quantum dot-Photofrin conjugate is only activated when radiation is applied.

Also, the area to be treated is targeted with conformal radiation, which is delivered with high precision within the three-dimensional contours of the tumour, with minimal spillover to surrounding healthy tissues.

Consequently, Yang says, "the toxicity of the drug is substantially lower in the lower radiation dose area" outside the boundaries of the tumour.

In tests on human lung carcinoma cells, the process resulted in a two-six times lower tumour cell survival compared to radiation alone, but with minimal toxicity to nearby cells.

Source: ANI
RAS/L
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

Exploring How Hearing Impairment Shapes Dementia Risk
Study reveals a correlation between hearing impairment and distinct brain region variances, contributing to dementia.
Coffee and its Role in Neurodegenerative Disorders
Financial impact of caring for individuals with neurodegenerative disorders reaches hundreds of billions annually in the United States.
Healthcare Industry Struggles With Tech Skills Shortage
Experts emphasize that addressing the skills gap demands immediate attention and innovative solutions, including education, re-training, and significant time investment.
Nano-Probes Uncover Cellular Reactions to Pressure
New study unveiled the cells' ability to adapt in responses and potential implications for conditions such as diabetes and cancer.
Brain Cells to Taste Buds Monitor Mindful Eating
Brainstem recording of tastebud neurons reveals the process of overindulgence of food, opening new avenues for weight loss drugs.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Tumor Cells can Be Killed With Nanoparticles and Light Combo Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests